Winston Pharmaceuticals Management
Management criteria checks 1/4
We currently do not have sufficient information about the CEO.
Key information
Joel Bernstein
Chief executive officer
n/a
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 27yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 15.7yrs |
Recent management updates
No updates
Recent updates
CEO
Joel Bernstein (80 yo)
27yrs
Tenure
US$506,900
Compensation
Dr. Joel E. Bernstein, M.D., is the Founder, Chairman and Chief Executive Officer of Gideon Pharmaceuticals, Inc. Dr. Bernstein serves as Chief Executive Officer and President of Winston Pharmaceuticals In...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Founder | 26yrs | US$506.90k | no data | |
| Independent Chairman | 16yrs | US$48.83k | no data | |
| Director | 15.3yrs | US$381.59k | no data | |
| Independent Director | 15.3yrs | US$45.18k | no data |
15.7yrs
Average Tenure
80.5yo
Average Age
Experienced Board: WPHM's board of directors are seasoned and experienced ( 15.7 years average tenure).